1. Jacobs, R. F., Kaplan, S. L., Schutze, G. E., Dajani, A. S., Leggiadro, R. J., Rim, C. S. et al.1996 Relationship of MICs to efficacy of cefotaxime in treatment of Streptococcus pneumoniae infections. Antimicrobial Agents and Chemotherapy40,895– 8.
2. Hansman, D. & Bullen, M. M. 1967 A resistant pneumococcus. Lancetii, 264–5.
3. Appelbaum, P. C. 1992 Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clinical Infectious Diseases 15, 77–83.
4. Thornsberry, C., Ogilvie, P., Kahn, J. & Mauriz, Y. (1997). Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moxarella catarrhalis in the United States during the 1996– 97 respiratory season. In Program and Abstracts of the Thirty-Fifth Annual Meeting of the Infectious Diseases Society of America, Abstract 52, p. 12. ISDA, San Francisco, CA, USA.
5. National Committee for Clinical Laboratory Standards. (1997). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically— Fourth Edition: Approved Standard M7-A4. NCCLS, Villanova, PA.